340B Program: PhRMA Files Court Challenge to Interpretive Rule on Orphan Drug Exception

On Thursday, October 9, 2014, the Pharmaceutical Research and Manufacturers of America (PhRMA) filed suit against the Department of Health and Human Services (HHS) challenging the interpretive rule implementing the 340B statute's orphan drug exception. The complaint was filed in the U.S. District Court for the District of Columbia.

Read More: 340B Program: PhRMA Files Court Challenge to Interpretive Rule on Orphan Drug Exception


Download PDF Share Back To Listing
Loading data